Ngā hua rapu - Dmitriy Zamarin

Whakamahine hua
  1. 1
    Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions

    Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions mā Dmitriy Zamarin, Peter Palese

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers

    Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers mā Ying L. Liu, Dmitriy Zamarin

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells

    Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells mā Mena Mansour, Peter Palese, Dmitriy Zamarin

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Newcastle Disease Virus at the Forefront of Cancer Immunotherapy

    Newcastle Disease Virus at the Forefront of Cancer Immunotherapy mā Bharat Burman, Giulio Pesci, Dmitriy Zamarin

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice

    Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice mā Dmitriy Zamarin, Mila B. Ortigoza, Peter Palese

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1

    Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 mā Dmitriy Zamarin, Adolfo García‐Sastre, Xiaoyao Xiao, Rong Wang, Peter Palese

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer

    Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer mā Brandon A. Dyer, Dmitriy Zamarin, Ramez N. Eskandar, Jyoti M. Mayadev

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Tumor Immunity and Immunotherapy for HPV-Related Cancers

    Tumor Immunity and Immunotherapy for HPV-Related Cancers mā A. Shamseddine, Bharat Burman, Nancy Y. Lee, Dmitriy Zamarin, Nadeem Riaz

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Genetically engineered Newcastle disease virus for malignant melanoma therapy

    Genetically engineered Newcastle disease virus for malignant melanoma therapy mā Dmitriy Zamarin, Adam Vigil, Kaitlyn J. Kelly, Adolfo García‐Sastre, Yuman Fong

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

    Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressi... mā Rikke Holmgaard, Dmitriy Zamarin, Alexander M. Lesokhin, Taha Merghoub, Jedd D. Wolchok

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer

    Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer mā Kyo Young Song, Joyce Wong, Lorena González, Gang Sheng, Dmitriy Zamarin, Yuman Fong

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

    Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4 mā Rikke Holmgaard, Dmitriy Zamarin, David H. Munn, Jedd D. Wolchok, James P. Allison

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence

    A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence mā Gina M. Conenello, Dmitriy Zamarin, Lucy A. Perrone, Terrence M. Tumpey, Peter Palese

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways

    Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways mā Megan L. Shaw, Washington B. Cárdenas, Dmitriy Zamarin, Peter Palese, Christopher F. Basler

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein

    Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein mā Michelle Quinlivan, Dmitriy Zamarin, Adolfo García‐Sastre, Ann Cullinane, Thomas M. Chambers, Peter Palese

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Differential IL-10R1 Expression Plays a Critical Role in IL-10-Mediated Immune Regulation

    Differential IL-10R1 Expression Plays a Critical Role in IL-10-Mediated Immune Regulation mā Yaozhong Ding, Lihui Qin, Dmitriy Zamarin, Sergei V. Kotenko, Sidney Pestka, Kevin W. Moore, Jonathan S. Bromberg

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

    Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade mā Petar Jelinic, Jacob Ricca, Elke Van Oudenhove, Narciso Olvera, Taha Merghoub, Douglas A. Levine, Dmitriy Zamarin

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling

    Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling mā Shreya Raghavan, Catherine S. Snyder, Anni Wang, Karen McLean, Dmitriy Zamarin, Ronald J. Buckanovich, Geeta Mehta

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy

    Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy mā Jacob Ricca, Anton Oseledchyk, Tyler Walther, Cailian Liu, Levi Mangarin, Taha Merghoub, Jedd D. Wolchok, Dmitriy Zamarin

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer

    Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer mā Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Roisin E. O’Cearbhaill, Carol Aghajanian, Russell J. Schilder

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: